PLoS ONE · 2015 · 15 citations · 29 references
Life SciencesNutritionNutritional SciencesClinical NutritionHuman NutritionNeurodegenerationHuntington DiseaseNeurodegenerative DiseasesNeurodegenerative DisordersProtein NutritionUrea CycleUrea Cycle DisordersDietary Protein AdequacyDietary Protein MetabolismHtt GeneHuntingtin ProteinHuntington's Disease ModelsNutrition In Neurodegenerative DisordersProtein-restricted DietsUrea Cycle Enzyme Regulation
Huntington's disease (HD) is a neurodegenerative disorder caused by the huntingtin (HTT) gene with expanded CAG repeats. In addition to the apparent brain abnormalities, impairments also occur in peripheral tissues. We previously reported that mutant Huntingtin (mHTT) exists in the liver and causes urea cycle deficiency. A low protein diet (17%) restores urea cycle activity and ameliorates symptoms in HD model mice. It remains unknown whether the dietary protein content should be monitored closely in HD patients because the normal protein consumption is lower in humans (~15% of total calories) than in mice (~22%). We assessed whether dietary protein content affects the urea cycle in HD patients. Thirty HD patients were hospitalized and received a standard protein diet (13.7% protein) for 5 days, followed by a high protein diet (HPD, 26.3% protein) for another 5 days. Urea cycle deficiency was monitored by the blood levels of citrulline and ammonia. HD progression was determined by the Unified Huntington's Disease Rating Scale (UHDRS). The HPD increased blood citrulline concentration from 15.19 μmol/l to 16.30 μmol/l (p = 0.0378) in HD patients but did not change blood ammonia concentration. A 2-year pilot study of 14 HD patients found no significant correlation between blood citrulline concentration and HD progression. Our results indicated a short period of the HPD did not markedly compromise urea cycle function. Blood citrulline concentration is not a reliable biomarker of HD progression.
29
Manish A. Shah, Nicole A. Datson, Lakshmi Srinidhi et al. · Cell · 1993 · 3.1K citations
Unified Huntington's disease rating scale: Reliability and consistency
Movement Disorders · 1996 · 2.1K citations
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Motomasa Tanaka, Yoko Machida, Sanyong Niu et al. · Nature Medicine · 2004 · 778 citations